Gonorrhea Treatment Drugs Market Size

  • Report ID: 3077
  • Published Date: Dec 26, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Gonorrhea Treatment Market size is projected to witness around 3.6% CAGR during the forecast period i.e., between 2025-2037.

The growth of the gonorrhea treatment market can be attributed to the growing prevalence of gonorrhea, increasing incidents of unprotected sex, and rise in implementation of national screening programs. In 2018, more than 1.5 million gonococcal infections occurred in the United States. Among these, more than half of the people were aged between 15-24 years. Along with these, huge investments in the R&D activities to develop effective treatment options is also expected to drive market growth in the near future. Furthermore, improvement in healthcare infrastructure in developed nations and expanding advent of new diagnostic tests are evaluated to offer lucrative opportunities to the market in the coming years.


Global-Gonorrhea-Treatment-Drugs-Market

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

Gonorrhea Treatment Market size is projected to witness around 3.6% CAGR during the forecast period i.e., between 2025-2037.

Increasing prevalence of gonorrhea globally and growing implementation of national screening programs will impel the market growth.

North America industry is expected to dominate majority revenue share by 2037, on the back of easy availability of advanced technology and high standards of healthcare infrastructure in the region.

The major players in the market are Pfizer Inc., Allergan Inc., F. Hoffman-La Roche Ltd, GlaxoSmithKline plc., and others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos